BURIONI, ROBERTO
 Distribuzione geografica
Continente #
EU - Europa 1.321
AS - Asia 796
NA - Nord America 690
SA - Sud America 8
OC - Oceania 5
AF - Africa 1
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.822
Nazione #
US - Stati Uniti d'America 683
SE - Svezia 613
IT - Italia 407
CN - Cina 327
HK - Hong Kong 233
SG - Singapore 212
RU - Federazione Russa 145
FI - Finlandia 47
DE - Germania 27
NL - Olanda 23
IE - Irlanda 21
IN - India 10
FR - Francia 9
RO - Romania 9
GB - Regno Unito 8
SA - Arabia Saudita 6
CA - Canada 5
AU - Australia 4
BR - Brasile 4
EC - Ecuador 3
IR - Iran 3
AT - Austria 2
CZ - Repubblica Ceca 2
DO - Repubblica Dominicana 2
IS - Islanda 2
TW - Taiwan 2
AE - Emirati Arabi Uniti 1
BE - Belgio 1
BO - Bolivia 1
BY - Bielorussia 1
CH - Svizzera 1
DK - Danimarca 1
EU - Europa 1
LA - Repubblica Popolare Democratica del Laos 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
PL - Polonia 1
UA - Ucraina 1
ZA - Sudafrica 1
Totale 2.822
Città #
Shanghai 232
Hong Kong 231
Princeton 171
Lawrence 168
Singapore 144
Milan 97
Ashburn 85
Moscow 61
New York 46
Helsinki 45
Bologna 27
Rome 27
Ancona 21
Dublin 21
Boardman 19
Pune 10
Seattle 10
Guangzhou 9
Los Angeles 9
Marino 8
London 7
Shenzhen 7
Turin 7
Verona 7
Beijing 6
Washington 6
Borås 5
Dallas 5
Jeddah 5
Jiaxing 5
Xi'an 5
Catania 4
Scarpizzolo 4
Toronto 4
Brescia 3
Campagna 3
Ferrara 3
Florence 3
Frankfurt Am Main 3
Hangzhou 3
Melbourne 3
Padova 3
Riccione 3
Sorocaba 3
South San Francisco 3
Aversa 2
Bari 2
Bergamo 2
Bolgare 2
Caserta 2
Castel Volturno 2
Castrovillari 2
Cenaia 2
Cento 2
Changsha 2
Gatchina 2
Genoa 2
Naaldwijk 2
Nuremberg 2
Paderno Dugnano 2
Pomigliano d'Arco 2
Portland 2
Prague 2
Pratola Peligna 2
Quarto 2
Quito 2
Reykjavik 2
Rockville 2
Santa Clara 2
Seregno 2
Stimigliano 2
Taipei 2
Torre Annunziata 2
Vedelago 2
Amsterdam 1
Bisceglie 1
Bloemfontein 1
Brussels 1
Candia 1
Central 1
Cernusco sul Naviglio 1
Changzhi 1
Changzhou 1
Cherkessk 1
Chieti 1
Chongqing 1
Cornate d'Adda 1
Dongyang 1
Dubai 1
Espoo 1
Fasano 1
Fuzhou 1
Guayaquil 1
Hamilton 1
Hanover 1
Jinhua 1
Karachi 1
Krimpen Aan Den Ijssel 1
Kwai Chung 1
La Paz 1
Totale 1.635
Nome #
Salute : Le frontiere della medicina : Volumi dedicati alla Salute a cura di Roberto Burioni 148
Virus, la grande sfida : dal coronavirus alla peste : come la scienza può salvare l'umanità / Roberto Burioni ; con la collaborazione di Pier Luigi Lopalco 127
Cell-to-cell spread-blocking activity is extremely limited in the sera of HSV-1 and HSV-2 infected subjects 46
Cloning of the first human anti-JCPyV/VP1 neutralizing monoclonal antibody: Epitope definition and implications in risk stratification of patients under natalizumab therapy 36
Differential composition of vaginal microbiome, but not of seminal microbiome, is associated with successful intrauterine insemination in couples with idiopathic infertility: A prospective observational study 36
Broadly neutralizing anti-influenza human monoclonal antibodies and their possible role in predictive medicine 34
A Biologically-validated HCV E1E2 Heterodimer Structural Model 33
A Human Stem Cell-Derived Neurosensory–Epithelial Circuitry on a Chip to Model Herpes Simplex Virus Reactivation 32
A non-VH1-69 heterosubtypic neutralizing human monoclonal antibody protects mice against H1N1 and H5N1 viruses 31
Entry inhibition of HSV-1 and -2 protects mice from viral lethal challenge 31
Bacteriophages and Their Immunological Applications against Infectious Threats 31
A phage display vector optimized for the generation of human antibody combinatorial libraries and the molecular cloning of monoclonal antibody fragments 30
"Freezing" parasites in pre-Himalayan region, Himachal Pradesh: Experience with mini-FLOTAC 30
Combined Prophylactic and Therapeutic Use Maximizes Hydroxychloroquine Anti-SARS-CoV-2 Effects in vitro 29
Characterization of two human monoclonal anti-E2/HCV antibodies for potential application in prevention and treatment of HCV infection 27
66. Vaccini antivirali 27
Detection of low-level HCV variants in DAA treated patients: comparison amongst three different NGS data analysis protocols 27
Adoptive T-cell therapy in the treatment of viral and opportunistic fungal infections 26
A Human Monoclonal Antibody with Neutralizing Activity against Highly Divergent Influenza Subtypes 26
Novel therapeutic investigational strategies to treat severe and disseminated HSV infections suggested by a deeper understanding of in vitro virus entry processes 26
Interferon-β 1a inhibits SARS-CoV-2 in vitro when administered after virus infection 25
63. Vaccini Antivirali 24
A potential role for monoclonal antibodies in prophylactic and therapeutic treatment of influenza 24
Weak correlation between antibody titers and neutralizing activity in sera from SARS-CoV-2 infected subjects 24
Chimeric antigen receptor (CAR)-engineered T cells redirected against hepatitis C virus (HCV) E2 glycoprotein 24
HUMAN MONOCLONAL ANTIBODY ENDOWED WITH ANTI-HSV-1 AND -2 ACTIVITY STRONGLY INHIBITS VIRUS REPLICATION 23
Neutralization Interfering Antibodies: a "Novel" Mechanism of Humoral Immune Mutiny and Viral Evasion? 23
ANTI-HIV-1 RESPONSE ELICITED IN RABBITS BY ANTI-IDIOTYPE MONOCLONAL ANTIBODIES MIMICKING THE CD4-BINDING SITE ON GP120 23
Major sports events and the transmission of sars-cov-2: Analysis of seven case-studies in europe 23
A vector for the expression of recombinant monoclonal Fab fragments in bacteria 22
Influenza B-cells protective epitope characterization: a passkey for the rational design of new broad-range anti-influenza vaccines 22
Antigen-driven evolution of B lymphocytes in coronary atherosclerotic plaques 22
Acute respiratory distress in a neutropenic febrile patient after hematopoietic cell transplantation 22
Epitope mapping by epitope excision, hydrogen/deuterium exchange, and peptide-panning techniques combined with in silico analysis 22
Anti-HCV monoclonal antibody as a medicament for the therapeutic treatment and prevention of HCV infections 22
Answer to February 2019 Photo Quiz: Neurological Symptoms in a 74-Year-Old Diabetic Woman Admitted to the Emergency Room 22
IN VIVO PROTECTION CONFERRED BY HUMAN MONOCLONAL ANTIBODY DIRECTED AGAINST HSV-1 AND 2 22
Trends of Antimicrobial Susceptibility of Neisseria gonorrhoeae Isolates between 2012 and 2023: Results from an Open Italian Cohort 21
SARS-CoV-2 before and after Omicron: two different viruses and two different diseases? 21
Anti-HIV-1 response elicited in rabbits by anti-idiotype monoclonal antibodies mimicking the CD4-binding site 21
36. Meccanismi difensivi dell'ospite alle infezioni virali 21
Anti-idiotype monoclonal antibodies as mimotopes of the HIV gp120 antigen 21
Monoclonal antibodies as a medicament for the therapeutic and/or prophylactic treatment of swine-origin influenza A (H1N1) virus (S-OIV) infections 21
39 Meccanismi difensivi dell'ospite alle infezioni virali 20
A closer look at prion strains: Characterization and important implications 20
HCV E2 core structures and mAbs: something is still missing 20
Global and local envelope protein dynamics of hepatitis C virus determine broad antibody sensitivity 20
A novel efflux system in inducibly erythromycin-resistant strains of Streptococcus pyogenes 19
Characterization of epitopes recognized by monoclonal antibodies: experimental approaches supported by freely accessible bioinformatic tools 19
A new subtraction technique for molecular cloning of rare antiviral antibody specificities from phage display libraries 19
Human monoclonal recombinant antibody against NS3 HCV protein and methods therefor 19
Molecular diagnosis of sepsis in neutropenic patients with haematological malignancies 19
A recombinant human Fab inhibits helicase activity of HCVNS3 and negative strand RNA synthesis 19
Phage display for the production of human monoclonal antibodies against human pathogens 19
Molecular characterization of the human neutralizing response against hepatitis C virus and its role in the prediction of the infection outcome 19
A novel expression vector for production of epitope-tagged recombinant Fab-fragment in bacteria 18
Capitolo 39 Meccanismi difensivi dell'ospite alle infezioni virali 18
Monoclonal antibodies having homosubtype cross-neutralization properties against influenza A viruses subtype H1 18
Early molecular diagnosis of aspergillosis in a patient with acute myeloid leukaemia 18
Anti-HCV monoclonal antibody as a medicament for the therapeutic treatment and prevention of HCV infections 18
Synergy evaluation of anti-Herpes Simplex Virus type 1 and 2 compounds acting on different steps of virus life cycle 18
Role and potential therapeutic use of antibodies against herpetic infections 18
Photo quiz: Neurological symptoms in a 74-year-old diabetic woman admitted to the emergency room 18
Structural basis for a human broadly neutralizing influenza A hemagglutinin stem-specific antibody including H17/18 subtypes 17
A recombinant human Fab inhibits activity of HCVNS3 and negative strand RNA synthesis 17
Human Monoclonal Antibody Fab Fragments directed against HCV E2 glycoprotein and endowed with neutralizing activity 17
A recombinant human Fab inhibits helicase activity of HCVNS3 and negative strand RNA synthesis 17
Anticorpo monoclonale diretto contro il virus JC 17
Molecular study and epitope mapping of the human antibody response against HCV/E2 glycoprotein by generation of monoclonal recombinant Fabs. 17
HUMAN MONOCLONAL ANTIBODIES TO HERPES SIMPLEX VIRUS AND METHODS THEREFOR 16
Phage Display Technology 16
Method for the preparation of new oligoclonal antibodies 16
A NEW PLASMID CLONING VECTOR FOR DIRECT-DETECTION OF RECOMBINANT CLONES, BASED ON INACTIVATION OF A BACTERIAL ACID PHOSPHATASE-ENCODING GENE 16
Direct sequencing of Scedosporium apiospermum DNA in the diagnosis of a case of keratitis 16
Hepatitis C virus (HCV)-driven stimulation of subfamily-restricted natural IgM antibodies in mixed cryoglobulinemia 16
Has SARS-CoV-2 reached peak fitness? 16
Omeopatia : bugie, leggende e verità 16
Heterosubtypic protection conferred by the human monoclonal antibody PN-SIA28 against influenza A virus lethal infections in mice 15
Adaptive immunity against gut microbiota enhances apoE-mediated immune regulation and reduces atherosclerosis and western-diet-related inflammation 15
Phage display-based strategies for cloning and optimization of monoclonal antibodies directed against human pathogens 15
Assessing the human immune response to SARS-CoV-2 variants 15
An improved phage display vector for antibody repertoire cloning by construction of combinatorial libraries 14
Intracellular expression of recombinant human immunoglobulin (IGGI) against NS3 inhibits helicase activity and HCV replication in cell culture 14
Comparative Evaluation of the Bruker Biotyper and Vitek MS Matrix-Assisted Laser Desorption Ionization–Time Of Flight (MALDI-TOF) Mass Spectrometry Systems for Identification of Yeasts of Medical Importance 14
Humoral immune response against hepatitis C virus 14
Microbiological Diagnosis of Sepsis: The Confounding Effects of a “Gold Standard” 14
Enteric microbiome markers as early predictors of clinical outcome in allogeneic hematopoietic stem cell transplant (allo-HSCT): results of a prospective study in adult patients 14
Quantitation of Bacillus clausii in biological samples by real-time polymerase chain reaction 14
Hepatitis C virus (HCV) infection may elicit neutralizing antibodies targeting epitopes conserved in all viral genotypes 13
Heterogeneity of the humoral anti-HCV/E2 response in persistently infected patients as demonstrated by divergent patterns of inhibition of the binding of anti-HCV/E2 human monoclonal antibodies 13
Title: Acute respiratory distress in a neutropenic febrile patient after Hematopoietic Cell Transplantation 13
Risks of "blind" automated identification systems in medical microbiology 13
Blocking immunodominant epitopes by competitive deselection. 13
Divergent Trends of Anti-JCPyV Serum Reactivity and Neutralizing Activity in Multiple Sclerosis (MS) Patients during Treatment with Natalizumab 13
Correspondence: Italy's policy shift on immunization 13
Natalizumab-Associated Progressive Multifocal Leukoencephalopathy 13
La formidabile impresa. La medicina dopo la rivoluzione mRNA 12
Nonneutralizing human antibody fragments against hepatitis C virus E2 glycoprotein modulate neutralization of binding activity of human recombinant Fabs 12
Cloning and molecular characterization of a human recombinant IgG Fab binding to the Tat protein of human immunodeficiency virus type 1 (HIV-1) derived from the repertoire of a seronegative patient 12
Definition of biological activity and quantitation of different families of human anti-HCV/E2 antibodies by generation of human recombinant anti-E2 monoclonal Fab by phage display combinatorial repertoire library 12
Totale 2.264
Categoria #
all - tutte 44.908
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.908


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20206 0 0 0 0 0 0 5 0 0 0 0 1
2020/202113 4 0 0 3 3 1 1 0 0 1 0 0
2021/2022142 0 0 7 41 6 3 17 14 6 27 7 14
2022/20231.104 387 281 95 11 11 135 48 56 55 3 14 8
2023/2024530 24 38 79 62 29 100 11 43 4 38 19 83
2024/20251.052 292 34 45 131 72 225 253 0 0 0 0 0
Totale 2.973